Company announcement – No. 2 / 2021
The Capital Group Companies has notified Zealand about a change of its total holding of voting rights, in accordance with section 38 of the Capital Markets Act, and other financial instruments according to section 39(2)(1) of the Capital Markets Act and financial instruments with similar economic effect according to section 39(2)(2) of the Capital Markets Act, such that it now holds 5.61% of the voting rights of Zealand.
SMALLCAP World Fund, Inc., a fund managed by Capital Group Companies, Inc. has notified Zealand about a change of its total holding of share capital, in accordance with section 38 of the Capital Markets Act, and other financial instruments according to section 39(2)(1) of the Capital Markets Act and financial instruments with similar economic effect according to section 39(2)(2) of the Capital Markets Act, such that it now holds 5.61% of the voting rights of Zealand.
Please see further details in the attached notification forms.
# # #
About
Zealand was founded in 1998 in
Forward-Looking Statement
The above information contains forward-looking statements that provide Zealand Pharma’s expectations or forecasts of future events. Such forward-looking statements are subject to risks, uncertainties and inaccurate assumptions, which may cause actual results to differ materially from expectations set forth herein and may cause any or all of such forward-looking statements to be incorrect. If any or all of such forward-looking statements prove to be incorrect, our actual results could differ materially and adversely from those anticipated or implied by such statements. All such forward-looking statements speak only as of the date of this release and are based on information available to
For further information, please contact:
Zealand Pharma Investor Relations |
investors@zealandpharma.com |
Zealand Pharma Media Relations |
media@zealandpharma.com |
Attachments
- Standard Form_Zealand_Pharma_AS_CGC_2022 01 14
- Standard Form_Zealand_Pharma_AS_SCWF_2022 01 14
Source:
2022 GlobeNewswire, Inc., source